• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏肿瘤内钆潴留的磁共振成像模式。

MR imaging patterns of gadolinium retention within liver neoplasms.

作者信息

Peterson M S, Murakami T, Baron R L

机构信息

Department of Radiology, University of Pittsburgh Medical Center, PA 15213-2582, USA.

出版信息

Abdom Imaging. 1998 Nov-Dec;23(6):592-9. doi: 10.1007/s002619900410.

DOI:10.1007/s002619900410
PMID:9922191
Abstract

BACKGROUND

To determine the spectrum of appearances of gadolinium retention within cholangiocarcinoma (CCA) and other liver neoplasms.

METHODS

Two hundred ten patients underwent hepatic magnetic resonance imaging (MRI) at 1.5 T with precontrast T1- and T2-weighted spin-echo (SE) images and delayed Gd-DTPA- or gadoteridol- (0.1 mmol/kg) enhanced T1-weighted SE images. Postcontrast images were evaluated for lesions suspicious for tumors, and lesion signal intensity was characterized as homogeneously or heterogeneously hypo-, iso-, mildly hyper-, or markedly hyperintense to liver. Data from 94 patients with benign or malignant neoplasms are presented.

RESULTS

Imaging demonstrated 237 malignant neoplasms (121 hepatocellular carcinoma [HCC], 26 CCA, 17 colon carcinoma metastases, 73 other tumors) and 28 benign neoplasms (22 hemangioma, six focal nodular hyperplasia [FNH]). One hundred forty malignant lesions appeared as homogeneous postcontrast (29 hypointense, 75 isointense, 17 mildly hyperintense, 19 markedly hyperintense) and 97 as heterogeneous (15 isointense, 50 mildly hyperintense, 32 markedly hyperintense). Malignant lesions showing homogeneous, mildly or markedly hyperintense signal intensity postcontrast included 10 CCA, seven HCC, six epithelioid hemangioendothelioma, eight neuroendocrine tumor metastases, three adenocarcinoma metastases of unknown origin, and one breast carcinoma metastasis. Hemangiomas appeared as homogeneous postcontrast in 19 lesions (six isointense, one mildly hyperintense, 12 markedly hyperintense) and as heterogeneous in three lesions (markedly hyperintense). FNH appeared as homogeneous postcontrast in one lesion (isointense) and as heterogeneous in five lesions (one isointense, four mildly hyperintense).

CONCLUSION

Homogeneous gadolinium retention on delayed postcontrast images of malignant hepatic neoplasms is seen in a high percentage of CCA lesions and less commonly with other neoplasms.

摘要

背景

确定钆在胆管癌(CCA)及其他肝脏肿瘤中的留存表现谱。

方法

210例患者接受了1.5T的肝脏磁共振成像(MRI)检查,包括对比剂前的T1加权和T2加权自旋回波(SE)图像,以及延迟钆喷酸葡胺或钆特醇(0.1 mmol/kg)增强后的T1加权SE图像。对对比剂增强后的图像进行评估,以确定可疑肿瘤病变,并将病变信号强度特征化为相对于肝脏均匀或不均匀的低、等、轻度高或明显高信号。本文展示了94例良性或恶性肿瘤患者的数据。

结果

影像学检查显示237个恶性肿瘤(121个肝细胞癌[HCC]、26个CCA、17个结肠癌转移灶、73个其他肿瘤)和28个良性肿瘤(22个血管瘤、6个局灶性结节性增生[FNH])。140个恶性病变在对比剂增强后表现为均匀信号(29个低信号、75个等信号、17个轻度高信号、19个明显高信号),97个表现为不均匀信号(15个等信号、50个轻度高信号、32个明显高信号)。对比剂增强后表现为均匀、轻度或明显高信号强度的恶性病变包括10个CCA、7个HCC、6个上皮样血管内皮瘤、8个神经内分泌肿瘤转移灶、3个不明来源的腺癌转移灶和1个乳腺癌转移灶。血管瘤在19个病变中对比剂增强后表现为均匀信号(6个等信号、1个轻度高信号、12个明显高信号),3个病变表现为不均匀信号(明显高信号)。FNH在1个病变中对比剂增强后表现为均匀信号(等信号),5个病变表现为不均匀信号(1个等信号、4个轻度高信号)。

结论

在恶性肝脏肿瘤的延迟对比剂增强图像上,高比例的CCA病变可见均匀钆留存,其他肿瘤则较少见。

相似文献

1
MR imaging patterns of gadolinium retention within liver neoplasms.肝脏肿瘤内钆潴留的磁共振成像模式。
Abdom Imaging. 1998 Nov-Dec;23(6):592-9. doi: 10.1007/s002619900410.
2
[Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].肝脏局灶性病变的磁共振成像:钆对比剂与网状内皮肝细胞特异性对比剂的动态对比增强评估
Radiol Med. 2000 Oct;100(4):245-50.
3
Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.北美肝细胞癌:一项关于T1加权、T2加权及系列钆增强梯度回波图像表现的多机构研究
AJR Am J Roentgenol. 1998 Apr;170(4):1005-13. doi: 10.2214/ajr.170.4.9530051.
4
Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.钆喷酸葡胺增强磁共振成像对肝脏局灶性病变的特征性分析:使用不同回波时间的T1加权扰相梯度回波图像的效用
J Magn Reson Imaging. 2002 May;15(5):573-83. doi: 10.1002/jmri.10102.
5
[The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].[利用团注静脉注射钆喷酸葡胺通过快速小角度激发序列对肝脏局灶性病变进行动态磁共振研究]
Radiol Med. 1992 Apr;83(4):353-60.
6
Differentiation of hepatic hemangiomas from metastases by dynamic contrast-enhanced MR imaging.通过动态对比增强磁共振成像鉴别肝血管瘤与转移瘤
J Comput Assist Tomogr. 1990 Mar-Apr;14(2):205-16. doi: 10.1097/00004728-199003000-00009.
7
MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.神经内分泌肿瘤与肝血管瘤肝转移的磁共振诊断:动态钆螯合物增强梯度回波和非增强自旋回波图像的相对优点
AJR Am J Roentgenol. 1995 Dec;165(6):1407-13. doi: 10.2214/ajr.165.6.7484575.
8
Differentiation between multiple liver hemangiomas and liver metastases of gastrinomas: value of enhanced MRI.胃泌素瘤肝转移瘤与多发性肝血管瘤的鉴别:增强MRI的价值
J Comput Assist Tomogr. 1996 May-Jun;20(3):349-55. doi: 10.1097/00004728-199605000-00003.
9
Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.肝硬化中的肝细胞癌:钆和超顺磁性氧化铁增强T1加权磁共振成像的强化模式
Radiology. 2005 Nov;237(2):520-8. doi: 10.1148/radiol.2372041183. Epub 2005 Sep 28.
10
MR imaging of focal nodular hyperplasia of the liver: value of contrast-enhanced dynamic study.肝脏局灶性结节性增生的磁共振成像:对比增强动态研究的价值
Radiat Med. 1997 Jan-Feb;15(1):29-35.

引用本文的文献

1
Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.辅助成像特征在钆塞酸增强磁共振成像上鉴别硬化型肝细胞癌与肝内胆管细胞癌的价值。
Eur Radiol. 2018 Jun;28(6):2549-2560. doi: 10.1007/s00330-017-5196-y. Epub 2018 Jan 15.
2
Extracellular contrast agent-enhanced MRI: 15-min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with chronic liver disease.细胞外对比剂增强 MRI:15 分钟延迟期可提高慢性肝病患者肝细胞癌的诊断性能。
Eur Radiol. 2018 Apr;28(4):1551-1559. doi: 10.1007/s00330-017-5119-y. Epub 2017 Nov 13.
3
Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.
胆管癌:生物学、临床管理及药理学视角
ISRN Hepatol. 2014 Feb 16;2014:828074. doi: 10.1155/2014/828074. eCollection 2014.
4
Current status of intrahepatic cholangiocarcinoma.肝内胆管癌的现状
World J Gastroenterol. 2008 Nov 7;14(41):6289-97. doi: 10.3748/wjg.14.6289.
5
Diagnosis and initial management of cholangiocarcinoma with obstructive jaundice.伴有梗阻性黄疸的胆管癌的诊断与初始治疗
World J Gastroenterol. 2008 May 21;14(19):3000-5. doi: 10.3748/wjg.14.3000.
6
Magnetic Resonance Imaging of cholangiocarcinoma.磁共振成像在胆管癌中的应用。
Cancer Imaging. 2004 Apr 6;4(2):104-15. doi: 10.1102/1470-7330.2004.0018.
7
Cholangiocarcinoma: modern advances in understanding a deadly old disease.胆管癌:认识一种致命的古老疾病的现代进展
J Hepatol. 2006 Dec;45(6):856-67. doi: 10.1016/j.jhep.2006.09.001. Epub 2006 Sep 25.